MX338879B - Proceso de esterilizacion por filtracion en estado diluido para biopolimeros viscoelasticos. - Google Patents
Proceso de esterilizacion por filtracion en estado diluido para biopolimeros viscoelasticos.Info
- Publication number
- MX338879B MX338879B MX2010005276A MX2010005276A MX338879B MX 338879 B MX338879 B MX 338879B MX 2010005276 A MX2010005276 A MX 2010005276A MX 2010005276 A MX2010005276 A MX 2010005276A MX 338879 B MX338879 B MX 338879B
- Authority
- MX
- Mexico
- Prior art keywords
- biopolymers
- viscoelastic
- dilute
- sterilization process
- biopolymer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Genetics & Genomics (AREA)
- Sustainable Development (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente invención se refiere a los productos manufacturados de ácido hialurónico se utilizan en numerosas aplicaciones quirúrgicas que incluyen la complementación viscoelástica para el tratamiento de la osteoartritis, sin embargo, las técnicas de esterilización tradicionales dan por resultado la descomposición de estos biopolímeros viscoelásticos de alto peso molecular y de esta manera son inadecuadas. Se dan a conocer procesos para obtener soluciones estériles, concentradas de biopolímeros de alto peso molecular tal como el ácido hialurónico. Los procesos incluyen la esterilización por filtración con una preparación diluida del biopolímero y la concentración del biopolímero esterilizado por filtración, diluido mediante la ultrafiltración hasta una concentración deseada.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07120568 | 2007-11-13 | ||
PCT/IB2008/003042 WO2009063291A1 (en) | 2007-11-13 | 2008-11-12 | Dilute filtration sterilization process for viscoelastic biopolymers |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2010005276A MX2010005276A (es) | 2010-08-31 |
MX338879B true MX338879B (es) | 2016-05-04 |
Family
ID=39060256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010005276A MX338879B (es) | 2007-11-13 | 2008-11-12 | Proceso de esterilizacion por filtracion en estado diluido para biopolimeros viscoelasticos. |
Country Status (14)
Country | Link |
---|---|
US (3) | US20110130473A1 (es) |
EP (1) | EP2209814B1 (es) |
JP (1) | JP2011503047A (es) |
KR (1) | KR20100094982A (es) |
CN (1) | CN101855248B (es) |
AU (1) | AU2008322629B2 (es) |
CA (1) | CA2705850C (es) |
ES (1) | ES2622834T3 (es) |
IL (1) | IL205402A (es) |
MX (1) | MX338879B (es) |
NZ (1) | NZ584919A (es) |
PL (1) | PL2209814T3 (es) |
RU (1) | RU2501811C2 (es) |
WO (1) | WO2009063291A1 (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2209814B1 (en) | 2007-11-13 | 2017-01-25 | Bio-Technology General (Israel) Ltd. | Dilute filtration sterilization process for viscoelastic biopolymers |
JP5615271B2 (ja) * | 2008-06-18 | 2014-10-29 | オックスフォード バイオメディカ(ユーケー)リミテッド | ウイルス精製法 |
US8283463B2 (en) * | 2010-02-09 | 2012-10-09 | Bausch & Lomb Incorporated | Sterile hyaluronic acid solutions |
JP2011195604A (ja) * | 2010-03-17 | 2011-10-06 | Denki Kagaku Kogyo Kk | ヒアルロン酸及び/又はその塩の含有液中の異物除去方法 |
JP2011195607A (ja) * | 2010-03-17 | 2011-10-06 | Denki Kagaku Kogyo Kk | ヒアルロン酸及び/又はその塩の精製法 |
JP2011195608A (ja) * | 2010-03-17 | 2011-10-06 | Denki Kagaku Kogyo Kk | ヒアルロン酸及び/又はその塩の精製法 |
JP2011195611A (ja) * | 2010-03-17 | 2011-10-06 | Denki Kagaku Kogyo Kk | ヒアルロン酸及び/又はその塩の精製法 |
CN102492051B (zh) * | 2011-12-13 | 2013-08-28 | 中南大学 | 玉竹的深加工及综合利用工艺 |
TWI424007B (zh) | 2011-12-22 | 2014-01-21 | Ind Tech Res Inst | 使膠體交聯的方法與藉由此方法形成之經交聯的膠體 |
NZ628433A (en) * | 2012-01-20 | 2017-02-24 | Immunophotonics Inc | Chitosan-derived compositions |
CN102978257B (zh) * | 2012-12-20 | 2014-12-10 | 江苏久吾高科技股份有限公司 | 一种右旋糖酐的生产方法 |
US10519419B2 (en) * | 2014-01-23 | 2019-12-31 | Nissan Chemical Corporation | Method for producing culture medium composition |
CN104193850A (zh) * | 2014-08-16 | 2014-12-10 | 厦门世达膜科技有限公司 | 一种肝素钠粗品的生产方法 |
CN104804105B (zh) * | 2015-04-08 | 2018-04-27 | 成都郫县新星成明食品研究所 | 采用陶瓷膜过滤法制备卡拉胶的方法 |
MY195591A (en) | 2017-01-11 | 2023-02-02 | Ferring Bv | A Fast Disintegrating Pharmaceutical Composition |
CN110545824A (zh) | 2017-03-07 | 2019-12-06 | 持田制药株式会社 | 海藻酸液体制剂 |
WO2020016820A1 (en) | 2018-07-18 | 2020-01-23 | Bio-Technology General (Israel) Ltd. | Process of, and arrangement for, sterile filtering a non-newtonian liquid and formulation of a liquid obtainable thereby |
CN110760015B (zh) * | 2019-11-19 | 2022-07-22 | 河北鑫合生物化工有限公司 | 改进的三赞胶的提取方法 |
JPWO2023219171A1 (es) * | 2022-05-13 | 2023-11-16 |
Family Cites Families (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4141973A (en) * | 1975-10-17 | 1979-02-27 | Biotrics, Inc. | Ultrapure hyaluronic acid and the use thereof |
DE3244214A1 (de) * | 1982-11-30 | 1984-05-30 | B. Braun Melsungen Ag, 3508 Melsungen | Verfahren zur reinigung und fraktionierung von heparin |
US4517295A (en) * | 1983-02-18 | 1985-05-14 | Diagnostic, Inc. | Hyaluronic acid from bacterial culture |
US5093487A (en) * | 1986-01-06 | 1992-03-03 | Mobay Corporation | Low viscosity high molecular weight filter sterilizable hyaluronic acid |
US5316926A (en) * | 1983-11-25 | 1994-05-31 | Miles Inc. | Method for the microbiological production of non-antigenic hyaluronic acid |
NO161573C (no) * | 1983-11-25 | 1989-08-30 | Miles Inc | Fremgangsmaate til fremstilling av hyaluronsyre. |
FR2569724B1 (fr) | 1984-09-04 | 1991-02-08 | Chisso Corp | Procede pour la preparation d'acide hyaluronique |
US4780414A (en) * | 1985-01-18 | 1988-10-25 | Bio-Technology General Corp. | Method of producing high molecular weight sodium hyallronate by fermentation of streptococcus |
US4784990A (en) * | 1985-01-18 | 1988-11-15 | Bio-Technology General Corporation | High molecular weight sodium hyaluronate |
US4713448A (en) * | 1985-03-12 | 1987-12-15 | Biomatrix, Inc. | Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues |
US5099013A (en) * | 1985-03-12 | 1992-03-24 | Biomatrix, Inc, | Hylan preparation and method of recovery thereof from animal tissues |
US4851521A (en) * | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
US4746504A (en) * | 1986-03-14 | 1988-05-24 | Bio-Technology General Corp. | Heavy metal salts of hyaluronic acid and their use as antimicrobial agents |
AU600483B2 (en) * | 1986-03-14 | 1990-08-16 | Bio-Technology General Corporation | Heavy metal salts of hyaluronic acid |
US5023175A (en) * | 1986-05-01 | 1991-06-11 | Kabushiki Kaisha Yakult Honsha | Novel production process of hyaluronic acid and bacterium strain therefor |
JPS6394988A (ja) * | 1986-10-08 | 1988-04-26 | Meiji Seika Kaisha Ltd | ヒアルロン酸の製造法 |
JPS6394988U (es) | 1986-12-04 | 1988-06-18 | ||
US5079236A (en) * | 1987-05-27 | 1992-01-07 | Hyal Pharmaceutical Corporation | Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use |
FR2620130B1 (fr) * | 1987-09-08 | 1990-01-12 | Lipha | Nouveaux polysaccharides hydrosolubles, leur procede d'obtention, leur application a titre de medicaments et preparation les renfermant |
US5017751A (en) * | 1990-06-21 | 1991-05-21 | Gte Laboratories Incorporated | Inductively-coupled RF plasma torch |
US5213964A (en) * | 1990-07-16 | 1993-05-25 | Cholestech Corporation | High-density lipoprotein solid-base precipitation assay method |
FR2668163B1 (fr) * | 1990-10-18 | 1993-01-15 | Orsan | Procede de fabrication de beta-cyclodextrine. |
JPH0630605B2 (ja) * | 1990-10-23 | 1994-04-27 | チッソ株式会社 | ヒアルロン酸ナトリウム水溶液の製造法 |
GB9024223D0 (en) * | 1990-11-07 | 1990-12-19 | Fermentech Ltd | Production of hyaluronic acid |
IT1247175B (it) * | 1991-04-19 | 1994-12-12 | Fidia Spa | Procedimento per la purificazione di acido ialuronico e frazione di acido ialuronico puro per uso oftalmico. |
AU3065192A (en) * | 1991-12-20 | 1993-07-28 | Howmedica Inc. | Ultra-pure polysaccharide materials for medical use |
US5266326A (en) * | 1992-06-30 | 1993-11-30 | Pfizer Hospital Products Group, Inc. | In situ modification of alginate |
IT1263393B (it) * | 1993-07-30 | 1996-08-05 | Fidia Advanced Biopolymers Srl | Processo per la preparazione e purificazione di acido ialuronico ad alto peso molecolare |
IT1268954B1 (it) | 1994-03-11 | 1997-03-18 | Fidia Advanced Biopolymers Srl | Processo per la preparazione di acido ialuronico mediante sintesienzimatica e relative composizioni farmaceutiche |
ITPD940054A1 (it) | 1994-03-23 | 1995-09-23 | Fidia Advanced Biopolymers Srl | Polisaccaridi solfatati |
US6017901A (en) * | 1995-05-10 | 2000-01-25 | Fidia Advanced Bioplymers S.R.L. | Heavy metal salts of succinic acid hemiesters with hyaluronic acid or hyaluronic acid esters, a process for their preparation and relative pharmaceutical compositions |
IT1282219B1 (it) * | 1995-12-20 | 1998-03-16 | Fidia Advanced Biopolymers Srl | Processo chimico fisico combinato per la preparazione di frazioni di acido ialuronico a basso peso molecolare caratterizzate da bassa |
US6221854B1 (en) * | 1996-03-05 | 2001-04-24 | Orquest, Inc. | Method of promoting bone growth with hyaluronic acid and growth factors |
US6602693B1 (en) * | 1996-07-03 | 2003-08-05 | Clear Solutions Biotech, Inc. | Gene encoding hyaluronan synthase |
IT1287698B1 (it) | 1996-08-29 | 1998-08-18 | Fidia Advanced Biopolymers Srl | Fili da sutura essenzialmente costituiti da derivati esterei dello acido ialuronico |
EP0949275B1 (en) * | 1996-12-27 | 2003-07-16 | Kao Corporation | Method for the purification of ionic polymers |
ES2189166T3 (es) | 1997-04-04 | 2003-07-01 | Fidia Advanced Biopolymers Srl | Compuestos del acido hialuronico n-sulfatado, sus derivados y proceso para su preparacion. |
AU9685298A (en) * | 1997-10-07 | 1999-04-27 | Bio-Technology General Corporation | Device for administration of viscoelastic substance |
FR2785910B1 (fr) * | 1998-11-16 | 2002-06-07 | Aquamer | Procede d'obtention, a partir du milieu de culture de micro-algues, d'un extrait thermostable possedant une activite anti-oxydante et pro-cicatrisante |
AU3032400A (en) | 1998-12-23 | 2000-07-31 | Friedrich-Schiller-Universitat Jena | Pharmaceutical formulation containing a microbial enzyme which digests hyaluronic acid |
CH692919A5 (fr) * | 1999-01-28 | 2002-12-13 | Trb Chemedica S A | Procédé de purification de l'acide hyaluronique à poids moléculaire élevé. |
IT1306643B1 (it) * | 1999-04-08 | 2001-10-02 | Fidia Advanced Biopolymers Srl | Processo per la preparazione dei composti autoreticolati dell'acidoialuronico e dei suoi derivati ottenibili mediante la tecnica |
ES2225241T3 (es) | 1999-10-15 | 2005-03-16 | Genetics Institute, Llc | Formulaciones de acido hialuronico para suministrar proteinas osteogenicas. |
US7166733B2 (en) * | 2000-01-04 | 2007-01-23 | Access Pharmaceuticals, Inc. | O,O'-Amidomalonate and N,O-Amidomalonate platinum complexes |
AU2762101A (en) * | 2000-01-04 | 2001-07-16 | Access Pharmaceuticals, Inc. | N,o-amidomalonate platinum complexes |
US6383344B1 (en) * | 2000-07-19 | 2002-05-07 | Genzyme Corporation | Molecular weight reduction of polymer using irradiation treatment |
US6660853B2 (en) * | 2000-12-15 | 2003-12-09 | Al Prescott | Method for purifying high molecular weight hyaluronic acid |
PL217885B1 (pl) | 2002-08-07 | 2014-08-29 | Medidom Lab | Sposób wytwarzania sterylnej, gotowej do użycia, wodnej formulacji farmaceutycznej, zawierającej sól wysokocząsteczkowego kwasu hialuronowego |
RU2280041C1 (ru) * | 2005-04-21 | 2006-07-20 | Общество с ограниченной ответственностью Научно-производственное предприятие "Тульская индустрия ЛТД" | Способ получения водорастворимых солевых комплексов гиалуроновой кислоты (варианты) |
EP1976857A4 (en) * | 2006-01-13 | 2011-08-03 | Baxter Int | PROCESS FOR CLEANING POLYSACCHARIDES |
EP2209814B1 (en) | 2007-11-13 | 2017-01-25 | Bio-Technology General (Israel) Ltd. | Dilute filtration sterilization process for viscoelastic biopolymers |
-
2008
- 2008-11-12 EP EP08849793.8A patent/EP2209814B1/en active Active
- 2008-11-12 CN CN2008801157224A patent/CN101855248B/zh active Active
- 2008-11-12 MX MX2010005276A patent/MX338879B/es active IP Right Grant
- 2008-11-12 US US12/742,861 patent/US20110130473A1/en not_active Abandoned
- 2008-11-12 RU RU2010118163/13A patent/RU2501811C2/ru active
- 2008-11-12 NZ NZ584919A patent/NZ584919A/en unknown
- 2008-11-12 PL PL08849793T patent/PL2209814T3/pl unknown
- 2008-11-12 CA CA2705850A patent/CA2705850C/en active Active
- 2008-11-12 AU AU2008322629A patent/AU2008322629B2/en active Active
- 2008-11-12 JP JP2010532673A patent/JP2011503047A/ja active Pending
- 2008-11-12 ES ES08849793.8T patent/ES2622834T3/es active Active
- 2008-11-12 WO PCT/IB2008/003042 patent/WO2009063291A1/en active Application Filing
- 2008-11-12 KR KR1020107012081A patent/KR20100094982A/ko not_active Application Discontinuation
-
2010
- 2010-04-28 IL IL205402A patent/IL205402A/en active IP Right Grant
-
2013
- 2013-09-10 US US14/023,196 patent/US9896518B2/en active Active
-
2018
- 2018-01-22 US US15/876,645 patent/US20180142041A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MX2010005276A (es) | 2010-08-31 |
RU2010118163A (ru) | 2011-12-20 |
RU2501811C2 (ru) | 2013-12-20 |
ES2622834T3 (es) | 2017-07-07 |
AU2008322629B2 (en) | 2013-05-16 |
NZ584919A (en) | 2012-05-25 |
EP2209814A1 (en) | 2010-07-28 |
KR20100094982A (ko) | 2010-08-27 |
AU2008322629A1 (en) | 2009-05-22 |
JP2011503047A (ja) | 2011-01-27 |
WO2009063291A8 (en) | 2009-09-17 |
PL2209814T3 (pl) | 2017-08-31 |
IL205402A (en) | 2015-10-29 |
IL205402A0 (en) | 2010-12-30 |
CA2705850A1 (en) | 2009-05-22 |
CN101855248B (zh) | 2012-08-22 |
CN101855248A (zh) | 2010-10-06 |
WO2009063291A1 (en) | 2009-05-22 |
CA2705850C (en) | 2016-07-19 |
US9896518B2 (en) | 2018-02-20 |
EP2209814B1 (en) | 2017-01-25 |
US20110130473A1 (en) | 2011-06-02 |
US20180142041A1 (en) | 2018-05-24 |
US20140018315A1 (en) | 2014-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX338879B (es) | Proceso de esterilizacion por filtracion en estado diluido para biopolimeros viscoelasticos. | |
ATE420116T1 (de) | Verfahren zur herstellung von cellulosesulfat mit verbesserten eigenschaften | |
WO2009005790A3 (en) | Sterile thiol-derivatized hyaluronic acid polymer compositions and uses thereof | |
ITPD20050206A1 (it) | Biomateriali in forma di fibra da impiegarsi come dispositivi medici nel trattamento delle ferite e loro processi di produzione | |
AR076607A1 (es) | Composicion acuosa. metodo para producir una preparacion altamente concentrada de inmunoglobulina de uso subcutaneo | |
EP2783573A3 (en) | Long shelf life milk and milk-related products, and a process and milk processing plant for their manufacture | |
WO2009125297A3 (es) | Método para la producción de la composición de ácido hipocloroso y aplicaciones | |
CL2011002021A1 (es) | Procedimiento de preparacion de una composicion enriquecida en compuestos fenolicos con una masa molecular inferior a 400 da, a partir de aguas de vegetacion de aceitunas, que comprende clarificacion de dichas aguas, ultrafiltracion tangencial de las aguas de vegetacion clarificadas, nanofiltracion del permeado, adsorcion de los compuestos fenolicos y concentracion. | |
JP2018168263A (ja) | 植物性プロテオグリカン及びその用途 | |
JO2798B1 (en) | (Oxazolidinone-5-yl-methyl) -2-Thiophene-carboxamides substituted and used in blood clotting | |
KR20190101425A (ko) | 오존을 이용한 다당류 분해 방법 | |
PH12019501469A1 (en) | Compositions and methods for treating biofilms | |
BR102015003197A8 (pt) | processo de produção em escala de hidrogel de celulose bacteriana purificada obtida pela polimerização da glicose a partir de açúcares de fontes renováveis via biotecnologia por meio da propagação de bactérias produtoras de celulose particularmente gluconoacetobacter hansenii lmspe, em reatores para aplicação nas áreas de saúde, farmacotécnica e cosmiatria | |
HK1144574A1 (en) | Substituted (oxazolidinon-5-yl-methyl)-2-thiophene-carboxamides and use thereof in the field of blood coagulation | |
CN104367507A (zh) | 一种皮肤护理液及其制备方法 | |
CN102604132A (zh) | 电子束辐射交联壳聚糖的方法 | |
FR2968004B1 (fr) | Films naturels biodegradables a base de co-produits issus de processus industriels de traitement de graines. | |
Michael et al. | Marine polysaccharides: properties and applications | |
CN107637596A (zh) | 一种南瓜种子消毒剂 | |
BR112014005221A2 (pt) | uso de materiais de fibra oca modificada para a remoção de exotoxinas produzidas por escherichia coli a partir de liquidos, de preferência a partir de sangue e de plasma, bem como seu uso para o tratamento de doenças concomitantes | |
JP5758878B2 (ja) | ヒアルロン酸の精製方法 | |
KR20120021891A (ko) | 저분자화 베타글루칸의 제조방법 | |
CN204251454U (zh) | 新型一级反渗透装置 | |
Popa | Polysaccharides in medicinal and pharmaceutical applications | |
EP2326667A4 (en) | PROTEINIC ACID POLYMER, METHOD OF MANUFACTURE, USE OF PROTEINIC POLYMER, PHARMACEUTICAL COMPOSITION AND TREATMENT METHOD |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |